The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion

Autor: Andreasson, ASI, Borthwick, LA, Gillespie, C, Jiwa, K, Scott, J, Henderson, P, Mayes, J, Romano, R, Roman, M, Ali, S, Fildes, JE, Marczin, N, Dark, JH, Fisher, AJ, DEVELOP-UK Investigators

Publikováno v: Andreasson, A S I, Borthwick, L A, Gillespie, C, Jiwa, K, Scott, J, Henderson, P, Mayes, J, Romano, R, Roman, M, Ali, S, Fildes, J E, Marczin, N, Dark, J H & Fisher, A J 2017, ' The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion ', Journal of Heart and Lung Transplantation . https://doi.org/10.1016/j.healun.2017.05.012
The Journal of Heart and Lung Transplantation

Background: Extended criteria donor lungs deemed unsuitable for immediate transplantation can be reconditioned using ex vivo lung perfusion (EVLP). Objective identification of which donor lungs can be successfully reconditioned and will function well

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d95726514a9dd06140a6b800ab19b6f9
http://www.scopus.com/inward/record.url?scp=85019542085&partnerID=8YFLogxK

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immunological mechanisms of pentoxifylline in chronic heart failure.

Autor: Shaw SM, Shah MK, Williams SG, Fildes JE, Shaw, Steven M, Shah, Mohammed K H, Williams, Simon G, Fildes, James E

Publikováno v: European Journal of Heart Failure; Feb2009, Vol. 11 Issue 2, p113-118, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The interpretation of clinical trial data--wrongly ACCLAIM'ed?

Autor: Shaw SM, Yonan N, Williams SG, Fildes JE

Publikováno v: American Heart Journal; Aug2009, Vol. 158 Issue 2, p149-151, 3p